HB1293 Enrolled LRB096 09536 ASK 19695 b

1     AN ACT concerning professional regulation.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Pharmacy Practice Act is amended by changing
5 Sections 3, 9, 9.5, 16a, 25.15, 30, and 35.16 as follows:
 
6     (225 ILCS 85/3)  (from Ch. 111, par. 4123)
7     (Section scheduled to be repealed on January 1, 2018)
8     Sec. 3. Definitions. For the purpose of this Act, except
9 where otherwise limited therein:
10     (a) "Pharmacy" or "drugstore" means and includes every
11 store, shop, pharmacy department, or other place where
12 pharmacist care is provided by a pharmacist (1) where drugs,
13 medicines, or poisons are dispensed, sold or offered for sale
14 at retail, or displayed for sale at retail; or (2) where
15 prescriptions of physicians, dentists, advanced practice
16 nurses, physician assistants, veterinarians, podiatrists, or
17 optometrists, within the limits of their licenses, are
18 compounded, filled, or dispensed; or (3) which has upon it or
19 displayed within it, or affixed to or used in connection with
20 it, a sign bearing the word or words "Pharmacist", "Druggist",
21 "Pharmacy", "Pharmaceutical Care", "Apothecary", "Drugstore",
22 "Medicine Store", "Prescriptions", "Drugs", "Dispensary",
23 "Medicines", or any word or words of similar or like import,

 

 

HB1293 Enrolled - 2 - LRB096 09536 ASK 19695 b

1 either in the English language or any other language; or (4)
2 where the characteristic prescription sign (Rx) or similar
3 design is exhibited; or (5) any store, or shop, or other place
4 with respect to which any of the above words, objects, signs or
5 designs are used in any advertisement.
6     (b) "Drugs" means and includes (l) articles recognized in
7 the official United States Pharmacopoeia/National Formulary
8 (USP/NF), or any supplement thereto and being intended for and
9 having for their main use the diagnosis, cure, mitigation,
10 treatment or prevention of disease in man or other animals, as
11 approved by the United States Food and Drug Administration, but
12 does not include devices or their components, parts, or
13 accessories; and (2) all other articles intended for and having
14 for their main use the diagnosis, cure, mitigation, treatment
15 or prevention of disease in man or other animals, as approved
16 by the United States Food and Drug Administration, but does not
17 include devices or their components, parts, or accessories; and
18 (3) articles (other than food) having for their main use and
19 intended to affect the structure or any function of the body of
20 man or other animals; and (4) articles having for their main
21 use and intended for use as a component or any articles
22 specified in clause (l), (2) or (3); but does not include
23 devices or their components, parts or accessories.
24     (c) "Medicines" means and includes all drugs intended for
25 human or veterinary use approved by the United States Food and
26 Drug Administration.

 

 

HB1293 Enrolled - 3 - LRB096 09536 ASK 19695 b

1     (d) "Practice of pharmacy" means (1) the interpretation and
2 the provision of assistance in the monitoring, evaluation, and
3 implementation of prescription drug orders; (2) the dispensing
4 of prescription drug orders; (3) participation in drug and
5 device selection; (4) drug administration limited to the
6 administration of oral, topical, injectable, and inhalation as
7 follows: in the context of patient education on the proper use
8 or delivery of medications; vaccination of patients 14 years of
9 age and older pursuant to a valid prescription or standing
10 order, by a physician licensed to practice medicine in all its
11 branches, upon completion of appropriate training, including
12 how to address contraindications and adverse reactions set
13 forth by rule, with notification to the patient's physician and
14 appropriate record retention, or pursuant to hospital pharmacy
15 and therapeutics committee policies and procedures; (5) drug
16 regimen review; (6) drug or drug-related research; (7) the
17 provision of patient counseling; (8) the practice of
18 telepharmacy; (9) the provision of those acts or services
19 necessary to provide pharmacist care; (10) medication therapy
20 management; and (11) the responsibility for compounding and
21 labeling of drugs and devices (except labeling by a
22 manufacturer, repackager, or distributor of non-prescription
23 drugs and commercially packaged legend drugs and devices),
24 proper and safe storage of drugs and devices, and maintenance
25 of required records. A pharmacist who performs any of the acts
26 defined as the practice of pharmacy in this State must be

 

 

HB1293 Enrolled - 4 - LRB096 09536 ASK 19695 b

1 actively licensed as a pharmacist under this Act.
2     (e) "Prescription" means and includes any written, oral,
3 facsimile, or electronically transmitted order for drugs or
4 medical devices, issued by a physician licensed to practice
5 medicine in all its branches, dentist, veterinarian, or
6 podiatrist, or optometrist, within the limits of their
7 licenses, by a physician assistant in accordance with
8 subsection (f) of Section 4, or by an advanced practice nurse
9 in accordance with subsection (g) of Section 4, containing the
10 following: (l) name of the patient; (2) date when prescription
11 was issued; (3) name and strength of drug or description of the
12 medical device prescribed; and (4) quantity, (5) directions for
13 use, (6) prescriber's name, address and signature, and (7) DEA
14 number where required, for controlled substances. DEA numbers
15 shall not be required on inpatient drug orders.
16     (f) "Person" means and includes a natural person,
17 copartnership, association, corporation, government entity, or
18 any other legal entity.
19     (g) "Department" means the Department of Financial and
20 Professional Regulation.
21     (h) "Board of Pharmacy" or "Board" means the State Board of
22 Pharmacy of the Department of Financial and Professional
23 Regulation.
24     (i) "Secretary" means the Secretary of Financial and
25 Professional Regulation.
26     (j) "Drug product selection" means the interchange for a

 

 

HB1293 Enrolled - 5 - LRB096 09536 ASK 19695 b

1 prescribed pharmaceutical product in accordance with Section
2 25 of this Act and Section 3.14 of the Illinois Food, Drug and
3 Cosmetic Act.
4     (k) "Inpatient drug order" means an order issued by an
5 authorized prescriber for a resident or patient of a facility
6 licensed under the Nursing Home Care Act or the Hospital
7 Licensing Act, or "An Act in relation to the founding and
8 operation of the University of Illinois Hospital and the
9 conduct of University of Illinois health care programs",
10 approved July 3, 1931, as amended, or a facility which is
11 operated by the Department of Human Services (as successor to
12 the Department of Mental Health and Developmental
13 Disabilities) or the Department of Corrections.
14     (k-5) "Pharmacist" means an individual health care
15 professional and provider currently licensed by this State to
16 engage in the practice of pharmacy.
17     (l) "Pharmacist in charge" means the licensed pharmacist
18 whose name appears on a pharmacy license and who is responsible
19 for all aspects of the operation related to the practice of
20 pharmacy.
21     (m) "Dispense" or "dispensing" means the interpretation,
22 evaluation, and implementation of a prescription drug order,
23 including the preparation and delivery of a drug or device to a
24 patient or patient's agent in a suitable container
25 appropriately labeled for subsequent administration to or use
26 by a patient in accordance with applicable State and federal

 

 

HB1293 Enrolled - 6 - LRB096 09536 ASK 19695 b

1 laws and regulations. "Dispense" or "dispensing" does not mean
2 the physical delivery to a patient or a patient's
3 representative in a home or institution by a designee of a
4 pharmacist or by common carrier. "Dispense" or "dispensing"
5 also does not mean the physical delivery of a drug or medical
6 device to a patient or patient's representative by a
7 pharmacist's designee within a pharmacy or drugstore while the
8 pharmacist is on duty and the pharmacy is open.
9     (n) "Nonresident pharmacy" means a pharmacy that is located
10 in a state, commonwealth, or territory of the United States,
11 other than Illinois, that delivers, dispenses, or distributes,
12 through the United States Postal Service, commercially
13 acceptable parcel delivery service, or other common carrier, to
14 Illinois residents, any substance which requires a
15 prescription.
16     (o) "Compounding" means the preparation and mixing of
17 components, excluding flavorings, (1) as the result of a
18 prescriber's prescription drug order or initiative based on the
19 prescriber-patient-pharmacist relationship in the course of
20 professional practice or (2) for the purpose of, or incident
21 to, research, teaching, or chemical analysis and not for sale
22 or dispensing. "Compounding" includes the preparation of drugs
23 or devices in anticipation of receiving prescription drug
24 orders based on routine, regularly observed dispensing
25 patterns. Commercially available products may be compounded
26 for dispensing to individual patients only if all of the

 

 

HB1293 Enrolled - 7 - LRB096 09536 ASK 19695 b

1 following conditions are met: (i) the commercial product is not
2 reasonably available from normal distribution channels in a
3 timely manner to meet the patient's needs and (ii) the
4 prescribing practitioner has requested that the drug be
5 compounded.
6     (p) (Blank).
7     (q) (Blank).
8     (r) "Patient counseling" means the communication between a
9 pharmacist or a student pharmacist pharmacy intern under the
10 supervision of a pharmacist and a patient or the patient's
11 representative about the patient's medication or device for the
12 purpose of optimizing proper use of prescription medications or
13 devices. "Patient counseling" may include without limitation
14 (1) obtaining a medication history; (2) acquiring a patient's
15 allergies and health conditions; (3) facilitation of the
16 patient's understanding of the intended use of the medication;
17 (4) proper directions for use; (5) significant potential
18 adverse events; (6) potential food-drug interactions; and (7)
19 the need to be compliant with the medication therapy. A
20 pharmacy technician may only participate in the following
21 aspects of patient counseling under the supervision of a
22 pharmacist: (1) obtaining medication history; (2) providing
23 the offer for counseling by a pharmacist or student pharmacist
24 intern; and (3) acquiring a patient's allergies and health
25 conditions.
26     (s) "Patient profiles" or "patient drug therapy record"

 

 

HB1293 Enrolled - 8 - LRB096 09536 ASK 19695 b

1 means the obtaining, recording, and maintenance of patient
2 prescription information, including prescriptions for
3 controlled substances, and personal information.
4     (t) (Blank).
5     (u) "Medical device" means an instrument, apparatus,
6 implement, machine, contrivance, implant, in vitro reagent, or
7 other similar or related article, including any component part
8 or accessory, required under federal law to bear the label
9 "Caution: Federal law requires dispensing by or on the order of
10 a physician". A seller of goods and services who, only for the
11 purpose of retail sales, compounds, sells, rents, or leases
12 medical devices shall not, by reasons thereof, be required to
13 be a licensed pharmacy.
14     (v) "Unique identifier" means an electronic signature,
15 handwritten signature or initials, thumb print, or other
16 acceptable biometric or electronic identification process as
17 approved by the Department.
18     (w) "Current usual and customary retail price" means the
19 price that a pharmacy charges to a non-third-party payor.
20     (x) "Automated pharmacy system" means a mechanical system
21 located within the confines of the pharmacy or remote location
22 that performs operations or activities, other than compounding
23 or administration, relative to storage, packaging, dispensing,
24 or distribution of medication, and which collects, controls,
25 and maintains all transaction information.
26     (y) "Drug regimen review" means and includes the evaluation

 

 

HB1293 Enrolled - 9 - LRB096 09536 ASK 19695 b

1 of prescription drug orders and patient records for (1) known
2 allergies; (2) drug or potential therapy contraindications;
3 (3) reasonable dose, duration of use, and route of
4 administration, taking into consideration factors such as age,
5 gender, and contraindications; (4) reasonable directions for
6 use; (5) potential or actual adverse drug reactions; (6)
7 drug-drug interactions; (7) drug-food interactions; (8)
8 drug-disease contraindications; (9) therapeutic duplication;
9 (10) patient laboratory values when authorized and available;
10 (11) proper utilization (including over or under utilization)
11 and optimum therapeutic outcomes; and (12) abuse and misuse.
12     (z) "Electronic transmission prescription" means any
13 prescription order for which a facsimile or electronic image of
14 the order is electronically transmitted from a licensed
15 prescriber to a pharmacy. "Electronic transmission
16 prescription" includes both data and image prescriptions.
17     (aa) "Medication therapy management services" means a
18 distinct service or group of services offered by licensed
19 pharmacists, physicians licensed to practice medicine in all
20 its branches, advanced practice nurses authorized in a written
21 agreement with a physician licensed to practice medicine in all
22 its branches, or physician assistants authorized in guidelines
23 by a supervising physician that optimize therapeutic outcomes
24 for individual patients through improved medication use. In a
25 retail or other non-hospital pharmacy, medication therapy
26 management services shall consist of the evaluation of

 

 

HB1293 Enrolled - 10 - LRB096 09536 ASK 19695 b

1 prescription drug orders and patient medication records to
2 resolve conflicts with the following:
3         (1) known allergies;
4         (2) drug or potential therapy contraindications;
5         (3) reasonable dose, duration of use, and route of
6     administration, taking into consideration factors such as
7     age, gender, and contraindications;
8         (4) reasonable directions for use;
9         (5) potential or actual adverse drug reactions;
10         (6) drug-drug interactions;
11         (7) drug-food interactions;
12         (8) drug-disease contraindications;
13         (9) identification of therapeutic duplication;
14         (10) patient laboratory values when authorized and
15     available;
16         (11) proper utilization (including over or under
17     utilization) and optimum therapeutic outcomes; and
18         (12) drug abuse and misuse.
19 "Medication therapy management services" includes the
20 following:
21         (1) documenting the services delivered and
22     communicating the information provided to patients'
23     prescribers within an appropriate time frame, not to exceed
24     48 hours;
25         (2) providing patient counseling designed to enhance a
26     patient's understanding and the appropriate use of his or

 

 

HB1293 Enrolled - 11 - LRB096 09536 ASK 19695 b

1     her medications; and
2         (3) providing information, support services, and
3     resources designed to enhance a patient's adherence with
4     his or her prescribed therapeutic regimens.
5 "Medication therapy management services" may also include
6 patient care functions authorized by a physician licensed to
7 practice medicine in all its branches for his or her identified
8 patient or groups of patients under specified conditions or
9 limitations in a standing order from the physician.
10 "Medication therapy management services" in a licensed
11 hospital may also include the following:
12         (1) reviewing assessments of the patient's health
13     status; and
14         (2) following protocols of a hospital pharmacy and
15     therapeutics committee with respect to the fulfillment of
16     medication orders.
17     (bb) "Pharmacist care" means the provision by a pharmacist
18 of medication therapy management services, with or without the
19 dispensing of drugs or devices, intended to achieve outcomes
20 that improve patient health, quality of life, and comfort and
21 enhance patient safety.
22     (cc) "Protected health information" means individually
23 identifiable health information that, except as otherwise
24 provided, is:
25         (1) transmitted by electronic media;
26         (2) maintained in any medium set forth in the

 

 

HB1293 Enrolled - 12 - LRB096 09536 ASK 19695 b

1     definition of "electronic media" in the federal Health
2     Insurance Portability and Accountability Act; or
3         (3) transmitted or maintained in any other form or
4     medium.
5 "Protected health information" does not include individually
6 identifiable health information found in:
7         (1) education records covered by the federal Family
8     Educational Right and Privacy Act; or
9         (2) employment records held by a licensee in its role
10     as an employer.
11     (dd) "Standing order" means a specific order for a patient
12 or group of patients issued by a physician licensed to practice
13 medicine in all its branches in Illinois.
14     (ee) "Address of record" means the address recorded by the
15 Department in the applicant's or licensee's application file or
16 license file, as maintained by the Department's licensure
17 maintenance unit.
18     (ff) "Home pharmacy" means the location of a pharmacy's
19 primary operations.
20 (Source: P.A. 94-459, eff. 1-1-06; 95-689, eff. 10-29-07.)
 
21     (225 ILCS 85/9)  (from Ch. 111, par. 4129)
22     (Section scheduled to be repealed on January 1, 2018)
23     Sec. 9. Registration as pharmacy technician. Any person
24 shall be entitled to registration as a registered pharmacy
25 technician who is of the age of 16 or over, has not engaged in

 

 

HB1293 Enrolled - 13 - LRB096 09536 ASK 19695 b

1 conduct or behavior determined to be grounds for discipline
2 under this Act, is attending or has graduated from an
3 accredited high school or comparable school or educational
4 institution or received a GED, and has filed a written
5 application for registration on a form to be prescribed and
6 furnished by the Department for that purpose. The Department
7 shall issue a certificate of registration as a registered
8 pharmacy technician to any applicant who has qualified as
9 aforesaid, and such registration shall be the sole authority
10 required to assist licensed pharmacists in the practice of
11 pharmacy, under the supervision of a licensed pharmacist. A
12 registered pharmacy technician may, under the supervision of a
13 pharmacist, assist in the practice of pharmacy and perform such
14 functions as assisting in the dispensing process, offering
15 counseling, receiving new verbal prescription orders, and
16 having prescriber contact concerning prescription drug order
17 clarification. A registered pharmacy technician may not engage
18 in patient counseling, drug regimen review, or clinical
19 conflict resolution.
20     Beginning on January 1, 2010, within 2 years after initial
21 registration being employed as a registered technician, a
22 pharmacy technician must become certified by successfully
23 passing the Pharmacy Technician Certification Board (PTCB)
24 examination or another Board-approved pharmacy technician
25 examination and register as a certified pharmacy technician
26 with the Department in order to continue to perform pharmacy

 

 

HB1293 Enrolled - 14 - LRB096 09536 ASK 19695 b

1 technician's duties. This requirement does not apply to
2 pharmacy technicians registered hired prior to January 1, 2008.
3     Any person registered as a pharmacy technician who is also
4 enrolled in a first professional degree program in pharmacy in
5 a school or college of pharmacy or a department of pharmacy of
6 a university approved by the Department or has graduated from
7 such a program within the last 18 months, shall be considered a
8 "student pharmacist pharmacy intern" and entitled to use the
9 title "student pharmacist" pharmacy intern". A student
10 pharmacist pharmacy intern must meet all of the requirements
11 for registration as a pharmacy technician set forth in this
12 Section excluding the requirement of certification prior to the
13 second registration renewal and pay the required pharmacy
14 technician registration fees. A student pharmacist may, under
15 the supervision of a pharmacist, assist in the practice of
16 pharmacy and perform any and all functions delegated to him or
17 her by the pharmacist.
18     Any person seeking licensure as a pharmacist who has
19 graduated from a pharmacy program outside the United States
20 must register as a pharmacy technician and shall be considered
21 a "student pharmacist" and be entitled to use the title
22 "student pharmacist" while completing the 1,200 clinical hours
23 of training approved by the Board of Pharmacy described and for
24 no more than 18 months after completion of these hours. These
25 individuals are not required to become certified pharmacy
26 technicians while completing their Board approved clinical

 

 

HB1293 Enrolled - 15 - LRB096 09536 ASK 19695 b

1 training, but must become licensed as a pharmacist or become a
2 certified pharmacy technician before the second pharmacy
3 technician registration renewal following completion of the
4 Board approved clinical training.
5     The Department shall not renew the pharmacy technician
6 license of any person who has been registered as a "student
7 pharmacist" and has dropped out of or been expelled from an
8 ACPE accredited college of pharmacy, who has failed to complete
9 his or her 1,200 hours of Board approved clinical training
10 within 24 months or who has failed the pharmacist licensure
11 examination 3 times and shall require these individuals to meet
12 the requirements of and become registered a certified pharmacy
13 technician.
14     The Department, upon the recommendation of the Board, may
15 take any action set forth in Section 30 of this Act with regard
16 to registrations certificates pursuant to this Section.
17     Any person who is enrolled in a non-traditional Pharm.D.
18 program at an ACPE accredited college of pharmacy and is a
19 licensed pharmacist under the laws of another United States
20 jurisdiction shall be permitted to engage in the program of
21 practice experience required in the academic program by virtue
22 of such license. Such person shall be exempt from the
23 requirement of registration as a registered pharmacy
24 technician while engaged in the program of practice experience
25 required in the academic program.
26     An applicant for registration as a pharmacy technician may

 

 

HB1293 Enrolled - 16 - LRB096 09536 ASK 19695 b

1 assist a pharmacist in the practice of pharmacy for a period of
2 up to 60 days prior to the issuance of a certificate of
3 registration if the applicant has submitted the required fee
4 and an application for registration to the Department. The
5 applicant shall keep a copy of the submitted application on the
6 premises where the applicant is assisting in the practice of
7 pharmacy. The Department shall forward confirmation of receipt
8 of the application with start and expiration dates of practice
9 pending registration.
10 (Source: P.A. 95-689, eff. 10-29-07.)
 
11     (225 ILCS 85/9.5)
12     (Section scheduled to be repealed on January 1, 2018)
13     Sec. 9.5. Certified pharmacy technician.
14     (a) An individual registered as a pharmacy technician under
15 this Act may be registered receive certification as a certified
16 pharmacy technician, if he or she meets all of the following
17 requirements:
18         (1) He or she has submitted a written application in
19     the form and manner prescribed by the Department Board.
20         (2) He or she has attained the age of 18.
21         (3) He or she is of good moral character, as determined
22     by the Department.
23         (4) He or she has (i) graduated from pharmacy
24     technician training meeting the requirements set forth in
25     subsection (a) of Section 17.1 of this Act or (ii) obtained

 

 

HB1293 Enrolled - 17 - LRB096 09536 ASK 19695 b

1     documentation from the pharmacist-in-charge of the
2     pharmacy where the applicant is employed verifying that he
3     or she has successfully completed a training program and
4     has successfully completed an objective assessment
5     mechanism prepared in accordance with rules established by
6     the Department Board.
7         (5) He or she has successfully passed an examination
8     accredited by the National Organization of Certifying
9     Agencies, as approved and required by the Board.
10         (6) He or she has paid the required certification fees.
11     (b) No pharmacist whose license has been denied, revoked,
12 suspended, or restricted for disciplinary purposes may be
13 eligible to be registered as a certified pharmacy technician.
14     (c) The Department Board may, by rule, establish any
15 additional requirements for certification under this Section.
16     (d) A person who is not a registered pharmacy technician
17 and meets the requirements of this Section may register as a
18 certified pharmacy technician without first registering as a
19 pharmacy technician.
20 (Source: P.A. 95-689, eff. 10-29-07.)
 
21     (225 ILCS 85/16a)  (from Ch. 111, par. 4136a)
22     (Section scheduled to be repealed on January 1, 2018)
23     Sec. 16a. (a) The Department shall establish rules and
24 regulations, consistent with the provisions of this Act,
25 governing nonresident pharmacies, including pharmacies

 

 

HB1293 Enrolled - 18 - LRB096 09536 ASK 19695 b

1 providing services via the Internet, which sell, or offer for
2 sale, drugs, medicines, or other pharmaceutical services in
3 this State.
4     (b) The Department Board shall require and provide for an
5 annual nonresident special pharmacy registration for all
6 pharmacies located outside of this State that dispense
7 medications for Illinois residents and mail, ship, or deliver
8 prescription medications into this State. Nonresident special
9 pharmacy registration shall be granted by the Department Board
10 upon the disclosure and certification by a pharmacy:
11         (1) that it is licensed in the state in which the
12     dispensing facility is located and from which the drugs are
13     dispensed;
14         (2) of the location, names, and titles of all principal
15     corporate officers and all pharmacists who are dispensing
16     drugs to residents of this State;
17         (3) that it complies with all lawful directions and
18     requests for information from the board of pharmacy of each
19     state in which it is licensed or registered, except that it
20     shall respond directly to all communications from the Board
21     or Department concerning any emergency circumstances
22     arising from the dispensing of drugs to residents of this
23     State;
24         (4) that it maintains its records of drugs dispensed to
25     residents of this State so that the records are readily
26     retrievable from the records of other drugs dispensed;

 

 

HB1293 Enrolled - 19 - LRB096 09536 ASK 19695 b

1         (5) that it cooperates with the Board or Department in
2     providing information to the board of pharmacy of the state
3     in which it is licensed concerning matters related to the
4     dispensing of drugs to residents of this State; and
5         (6) that during its regular hours of operation, but not
6     less than 6 days per week, for a minimum of 40 hours per
7     week, a toll-free telephone service is provided to
8     facilitate communication between patients in this State
9     and a pharmacist at the pharmacy who has access to the
10     patients' records. The toll-free number must be disclosed
11     on the label affixed to each container of drugs dispensed
12     to residents of this State.
13 (Source: P.A. 95-689, eff. 10-29-07.)
 
14     (225 ILCS 85/25.15)
15     (Section scheduled to be repealed on January 1, 2018)
16     Sec. 25.15. Telepharmacy.
17     (a) In this Section, "telepharmacy" means the provision of
18 pharmacist care by a pharmacist that is accomplished through
19 the use of telecommunications or other technologies to patients
20 or their agents who are at a distance and are located within
21 the United States, and which follows all federal and State
22 laws, rules, and regulations with regard to privacy and
23 security.
24     (b) Any pharmacy engaged in the practice of telepharmacy
25 must meet all of the following conditions:

 

 

HB1293 Enrolled - 20 - LRB096 09536 ASK 19695 b

1         (1) All events involving the contents of an automated
2     pharmacy system must be stored in a secure location and may
3     be recorded electronically.
4         (2) An automated pharmacy or prescription dispensing
5     machine system may be used in conjunction with the
6     pharmacy's practice of telepharmacy after inspection and
7     approval by the Department.
8         (3) The pharmacist in charge shall:
9             (A) be responsible for the practice of
10         telepharmacy performed at a remote pharmacy, including
11         the supervision of any prescription dispensing machine
12         or automated medication system;
13             (B) ensure that the home pharmacy has sufficient
14         pharmacists on duty for the safe operation and
15         supervision of all remote pharmacies;
16             (C) ensure, through the use of a video and auditory
17         communication system, that a certified pharmacy
18         technician at the remote pharmacy has accurately and
19         correctly prepared any prescription for dispensing
20         according to the prescription;
21             (D) be responsible for the supervision and
22         training of certified pharmacy technicians at remote
23         pharmacies who shall be subject to all rules and
24         regulations; and
25             (E) ensure that patient counseling at the remote
26         pharmacy is performed by a pharmacist or student

 

 

HB1293 Enrolled - 21 - LRB096 09536 ASK 19695 b

1         pharmacist pharmacist intern.
2 (Source: P.A. 95-689, eff. 10-29-07.)
 
3     (225 ILCS 85/30)  (from Ch. 111, par. 4150)
4     (Section scheduled to be repealed on January 1, 2018)
5     Sec. 30. Refusal, revocation, or suspension.
6     (a) The Department may refuse to issue or renew, or may
7 revoke a license or registration, or may suspend, place on
8 probation, fine, or take any disciplinary or non-disciplinary
9 action as the Department may deem proper, including fines not
10 to exceed $10,000 for each violation, with regard to any
11 licensee or registrant In accordance with Section 11 of this
12 Act, the Department may refuse to issue, restore, or renew, or
13 may revoke, suspend, place on probation, or reprimand as the
14 Department may deem proper with regard to any license or
15 certificate of registration or may impose a fine upon a
16 licensee or registrant not to exceed $10,000 per violation for
17 any one or combination of the following causes:
18         1. Material misstatement in furnishing information to
19     the Department.
20         2. Violations of this Act, or the rules promulgated
21     hereunder.
22         3. Making any misrepresentation for the purpose of
23     obtaining licenses.
24         4. A pattern of conduct which demonstrates
25     incompetence or unfitness to practice.

 

 

HB1293 Enrolled - 22 - LRB096 09536 ASK 19695 b

1         5. Aiding or assisting another person in violating any
2     provision of this Act or rules.
3         6. Failing, within 60 days, to respond to a written
4     request made by the Department for information.
5         7. Engaging in unprofessional, dishonorable, or
6     unethical conduct of a character likely to deceive, defraud
7     or harm the public.
8         8. Discipline by another U.S. jurisdiction or foreign
9     nation, if at least one of the grounds for the discipline
10     is the same or substantially equivalent to those set forth
11     herein.
12         9. Directly or indirectly giving to or receiving from
13     any person, firm, corporation, partnership or association
14     any fee, commission, rebate or other form of compensation
15     for any professional services not actually or personally
16     rendered.
17         10. A finding by the Department that the licensee,
18     after having his license placed on probationary status has
19     violated the terms of probation.
20         11. Selling or engaging in the sale of drug samples
21     provided at no cost by drug manufacturers.
22         12. Physical illness, including but not limited to,
23     deterioration through the aging process, or loss of motor
24     skill which results in the inability to practice the
25     profession with reasonable judgment, skill or safety.
26         13. A finding that licensure or registration has been

 

 

HB1293 Enrolled - 23 - LRB096 09536 ASK 19695 b

1     applied for or obtained by fraudulent means.
2         14. The applicant or licensee has been convicted in
3     state or federal court of or entered a plea of guilty, nolo
4     contendere, or the equivalent in a state or federal court
5     to any crime which is a felony or any misdemeanor related
6     to the practice of pharmacy or , of which an essential
7     element is dishonesty.
8         15. Habitual or excessive use or addiction to alcohol,
9     narcotics, stimulants or any other chemical agent or drug
10     which results in the inability to practice with reasonable
11     judgment, skill or safety.
12         16. Willfully making or filing false records or reports
13     in the practice of pharmacy, including, but not limited to
14     false records to support claims against the medical
15     assistance program of the Department of Healthcare and
16     Family Services (formerly Department of Public Aid) under
17     the Public Aid Code.
18         17. Gross and willful overcharging for professional
19     services including filing false statements for collection
20     of fees for which services are not rendered, including, but
21     not limited to, filing false statements for collection of
22     monies for services not rendered from the medical
23     assistance program of the Department of Healthcare and
24     Family Services (formerly Department of Public Aid) under
25     the Public Aid Code.
26         18. Dispensing Repetitiously dispensing prescription

 

 

HB1293 Enrolled - 24 - LRB096 09536 ASK 19695 b

1     drugs without receiving a written or oral prescription in
2     violation of law.
3         19. Upon a finding of a substantial discrepancy in a
4     Department audit of a prescription drug, including
5     controlled substances, as that term is defined in this Act
6     or in the Illinois Controlled Substances Act.
7         20. Physical or mental illness or any other impairment
8     or disability, including without limitation deterioration
9     through the aging process or loss of motor skills that
10     results in the inability to practice with reasonable
11     judgment, skill or safety, or mental incompetence, as
12     declared by a court of competent jurisdiction.
13         21. Violation of the Health Care Worker Self-Referral
14     Act.
15         22. Failing to sell or dispense any drug, medicine, or
16     poison in good faith. "Good faith", for the purposes of
17     this Section, has the meaning ascribed to it in subsection
18     (u) of Section 102 of the Illinois Controlled Substances
19     Act. "Good faith", as used in this item (22), shall not be
20     limited to the sale or dispensing of controlled substances,
21     but shall apply to all prescription drugs.
22         23. Interfering with the professional judgment of a
23     pharmacist by any registrant under this Act, or his or her
24     agents or employees.
25         24. Failing to report within 60 days to the Department
26     any adverse final action taken against a pharmacist,

 

 

HB1293 Enrolled - 25 - LRB096 09536 ASK 19695 b

1     pharmacist technician, or certified pharmacist technician
2     by another licensing jurisdiction in any other state or any
3     territory of the United States or any foreign jurisdiction,
4     any governmental agency, any law enforcement agency, or any
5     court for acts or conduct similar to acts or conduct that
6     would constitute grounds for discipline as defined in this
7     Section.
8         25. Failing to comply with a subpoena issued in
9     accordance with Section 35.5 of this Act.
10         26. Disclosing protected health information in
11     violation of any State or federal law.
12     (b) The Department may refuse to issue or may suspend the
13 license or registration of any person who fails to file a
14 return, or to pay the tax, penalty or interest shown in a filed
15 return, or to pay any final assessment of tax, penalty or
16 interest, as required by any tax Act administered by the
17 Illinois Department of Revenue, until such time as the
18 requirements of any such tax Act are satisfied.
19     (c) The Department shall revoke the license or certificate
20 of registration issued under the provisions of this Act or any
21 prior Act of this State of any person who has been convicted a
22 second time of committing any felony under the Illinois
23 Controlled Substances Act, or who has been convicted a second
24 time of committing a Class 1 felony under Sections 8A-3 and
25 8A-6 of the Illinois Public Aid Code. A person whose license or
26 certificate of registration issued under the provisions of this

 

 

HB1293 Enrolled - 26 - LRB096 09536 ASK 19695 b

1 Act or any prior Act of this State is revoked under this
2 subsection (c) shall be prohibited from engaging in the
3 practice of pharmacy in this State.
4     (d) The Department may adopt rules for the imposition of
5 fines in disciplinary cases, not to exceed $10,000 for each
6 violation of this Act. Fines may be imposed in conjunction with
7 other forms of disciplinary action, but shall not be the
8 exclusive disposition of any disciplinary action arising out of
9 conduct resulting in death or injury to a patient. Fines shall
10 be paid within 60 days or as otherwise agreed to by the
11 Department. Any funds collected from such fines shall be
12 deposited in the Illinois State Pharmacy Disciplinary Fund.
13     (e) The entry of an order or judgment by any circuit court
14 establishing that any person holding a license or certificate
15 under this Act is a person in need of mental treatment operates
16 as a suspension of that license. A licensee may resume his or
17 her practice only upon the entry of an order of the Department
18 based upon a finding by the Board that he or she has been
19 determined to be recovered from mental illness by the court and
20 upon the Board's recommendation that the licensee be permitted
21 to resume his or her practice.
22     (f) The Department shall issue quarterly to the Board a
23 status of all complaints related to the profession received by
24 the Department.
25     (g) In enforcing this Section, the Board or the Department,
26 upon a showing of a possible violation, may compel any licensee

 

 

HB1293 Enrolled - 27 - LRB096 09536 ASK 19695 b

1 or applicant for licensure under this Act to submit to a mental
2 or physical examination or both, as required by and at the
3 expense of the Department. The examining physician, or
4 multidisciplinary team involved in providing physical and
5 mental examinations led by a physician consisting of one or a
6 combination of licensed physicians, licensed clinical
7 psychologists, licensed clinical social workers, licensed
8 clinical professional counselors, and other professional and
9 administrative staff, shall be those specifically designated
10 by the Department. The Board or the Department may order the
11 examining physician or any member of the multidisciplinary team
12 to present testimony concerning this mental or physical
13 examination of the licensee or applicant. No information,
14 report, or other documents in any way related to the
15 examination shall be excluded by reason of any common law or
16 statutory privilege relating to communication between the
17 licensee or applicant and the examining physician or any member
18 of the multidisciplinary team. The individual to be examined
19 may have, at his or her own expense, another physician of his
20 or her choice present during all aspects of the examination.
21 Failure of any individual to submit to a mental or physical
22 examination when directed shall be grounds for suspension of
23 his or her license until such time as the individual submits to
24 the examination if the Board finds, after notice and hearing,
25 that the refusal to submit to the examination was without
26 reasonable cause. If the Board finds a pharmacist, certified

 

 

HB1293 Enrolled - 28 - LRB096 09536 ASK 19695 b

1 pharmacy technician, or pharmacy technician unable to practice
2 because of the reasons set forth in this Section, the Board
3 shall require such pharmacist, certified pharmacy technician,
4 or pharmacy technician to submit to care, counseling, or
5 treatment by physicians or other appropriate health care
6 providers approved or designated by the Board as a condition
7 for continued, reinstated, or renewed licensure to practice.
8 Any pharmacist, certified pharmacy technician, or pharmacy
9 technician whose license was granted, continued, reinstated,
10 renewed, disciplined, or supervised, subject to such terms,
11 conditions, or restrictions, and who fails to comply with such
12 terms, conditions, or restrictions or to complete a required
13 program of care, counseling, or treatment, as determined by the
14 chief pharmacy coordinator or a deputy pharmacy coordinator,
15 shall be referred to the Secretary for a determination as to
16 whether the licensee shall have his or her license suspended
17 immediately, pending a hearing by the Board. In instances in
18 which the Secretary immediately suspends a license under this
19 subsection (g), a hearing upon such person's license must be
20 convened by the Board within 15 days after such suspension and
21 completed without appreciable delay. The Board shall have the
22 authority to review the subject pharmacist's, certified
23 pharmacy technician's, or pharmacy technician's record of
24 treatment and counseling regarding the impairment.
25 (Source: P.A. 95-331, eff. 8-21-07; 95-689, eff. 10-29-07.)
 

 

 

HB1293 Enrolled - 29 - LRB096 09536 ASK 19695 b

1     (225 ILCS 85/35.16)  (from Ch. 111, par. 4155.16)
2     (Section scheduled to be repealed on January 1, 2018)
3     Sec. 35.16. The Secretary Director may temporarily suspend
4 the license of a pharmacist or pharmacy, or the registration of
5 a , pharmacy technician or certified pharmacy technician
6 registration as a distributor, without a hearing,
7 simultaneously with the institution of proceedings for a
8 hearing provided for in Section 35.2 of this Act, if the
9 Secretary Director finds that evidence in his possession
10 indicates that a continuation in practice would constitute an
11 imminent danger to the public. In the event that the Secretary
12 Director suspends, temporarily, this license or registration
13 certificate without a hearing, a hearing by the Department must
14 be held within 15 days after such suspension has occurred, and
15 be concluded without appreciable delay.
16 (Source: P.A. 95-689, eff. 10-29-07.)